Peptide research index

23 compounds, ranked by how much indexed research references them. Every page links back to the underlying publications. Reference only, not guidance.

• KPV

  7 publications · 0 human studies

  2016–2026

• ARA-290

  6 publications · 5 human studies

  2012–2026

• Glutathione

  6 publications · 5 human studies

  2009–2026

• Tesamorelin

  6 publications · 5 human studies

  2019–2026

• NAD+

  6 publications · 4 human studies

  2003–2026

• Ipamorelin

  6 publications · 2 human studies

  1999–2026

• Semaglutide

  6 publications · 6 human studies

  2016–2026

• TB-500

  5 publications · 0 human studies

  2012–2026

• Melanotan I

  5 publications · 5 human studies

  2015–2026

• MOTS-c

  5 publications · 1 human studies

  2015–2026

• VIP

  5 publications · 3 human studies

  2010–2026

• SS-31

  5 publications · 1 human studies

  2024–2026

• Retatrutide "Big R3"

  5 publications · 4 human studies

  2023–2026

• DSIP

  5 publications · 4 human studies

  1987–2021

• Tirzepatide

  4 publications · 4 human studies

  2021–2026

• Cagrilintide

  4 publications · 4 human studies

  2021–2026

• Semax

  4 publications · 1 human studies

  2018–2025

• BPC-157

  4 publications · 2 human studies

  2011–2026

• Sermorelin

  4 publications · 2 human studies

  1999–2026

• GHK-Cu

  4 publications · 0 human studies

  2018–2026

• Selank

  4 publications · 3 human studies

  2008–2022

• Snap-8

  2 publications · 2 human studies

  2020–2024

• AHK-Cu

  1 publications · 0 human studies

  2007–2007